LIFECORE BIOMEDICAL, INC. Derivative Liability, Fair Value, Gross Liability
LIFECORE BIOMEDICAL, INC. (LFCR) had Derivative Liability, Fair Value, Gross Liability of $0 as of 2015-05-31, per its 10-K filed 2015-07-31.
Discontinued › Notes
us-gaap:DerivativeFairValueOfDerivativeLiability · last filed 2015-07-31
- 2015-05-31: Derivative Liability, Fair Value, Gross Liability $0.00.
- 2015-03-01: Derivative Liability, Fair Value, Gross Liability $2.00K.
- 2014-11-30: Derivative Liability, Fair Value, Gross Liability $9.00K.
- 2014-08-31: Derivative Liability, Fair Value, Gross Liability $20.00K.
| Period end | Derivative Liability, Fair Value, Gross Liability |
|---|---|
| 2015-05-31 | $0.00 10-K · filed 2015-07-31 |
| 2015-03-01 | $2.00K 10-Q · filed 2015-04-02 |
| 2014-11-30 | $9.00K 10-Q · filed 2015-01-09 |
| 2014-08-31 | $20.00K 10-Q · filed 2014-10-08 |
| 2014-05-25 | $44.00K 10-K · filed 2015-07-31 |
| 2014-02-23 | $67.00K 10-Q · filed 2014-03-28 |
| 2013-11-24 | $95.00K 10-Q · filed 2014-01-03 |
| 2013-08-25 | $123.00K 10-Q · filed 2013-09-26 |
| 2013-05-26 | $163.00K 10-K · filed 2014-08-01 |
| 2013-02-24 | $203.00K 10-Q · filed 2013-04-04 |
| 2012-11-25 | $248.00K 10-Q · filed 2013-01-04 |
| 2012-05-27 | $347.00K 10-K · filed 2013-08-07 |
| 2012-05-23 | $305.00K 10-Q/A · filed 2013-01-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |